Market Overview:
The global oxaprozin active pharmaceutical ingredients market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for generic drugs. In addition, technological advancements in the field of drug discovery are also contributing to the growth of this market. However, stringent regulatory norms and high R&D costs are restraining the growth of this market. Based on type, the global oxaprozin active pharmaceutical ingredients market is segmented into purity (99%-99.5%), purity (above 99.5%), and purity (below 99%). The purity (above 99%) segment is expected to register highest CAGR during the forecast period owing to its high efficacy and safety profile as compared to other segments. Based on application, the global oxaprozin active pharmaceutical ingredients market is segmented into treating pain reliefs fever reliefs inflammation reliefs others). Among these applications, treating pain reliefs held majority share in 2017 and is projected to maintain its dominance during forecast period owing to increasing incidence of chronic pain across globe .Geographically ,the global oxaprozin active pharmaceutical ingredientsmarketis dividedinto North America Latin America Europe Asia Pacificand Middle East & Africa ).
Product Definition:
Oxaprozin is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, inflammation, and fever. It belongs to the family of drugs known as Cox-2 inhibitors.
Purity (99%-99.5%):
Purity (99%-99.5%) is a term used for pharmaceutical products that have been processed in such a way that they contain an amount of active ingredient equal to or greater than 99% and less than or equal to 99.5%. Pharmaceutical ingredients can be categorized into two groups, namely pure and hybrid drugs; the purity of an API depends on its intended use in pharmaceutical formulations.
Purity (above 99.5%):
Purity (above 99.5%) is a term used for pharmaceutical products that are free from any contaminant or impurity, which is why it's important to check the purity of the drug before using it in pharmaceuticals. The presence of even one particle per billion can have adverse effects on patients and cause severe illness or death.
Application Insights:
Reating pain accounted for the largest share of Oxaprozin API market in 2017. The drug is used to treat acute as well as chronic pains. Acute pain usually occurs due to injury and includes burns, headache, toothache, and abdominal pain. On the other hand, chronic or non-acute pains are caused by diseases such as arthritis and cancerous growths in the body that do not heal even with medication. Oxaprozin is also used for treating fever because of its anti-inflammatory property which helps reduce swelling along with other symptoms of inflammation such as redness & warmth at the site of infection.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to witness significant growth over the forecast period. The presence of key manufacturers such as Shandong Tianzhan Pharmaceutical Co., Ltd.; Sun Pharmaceutical Industries Ltd.; Cipla Inc.; Farsali Laboratories Pvt. Ltd; Avantor Performance Materials Inc.; and Nippon Paint Holdings Co.,Ltd has contributed to this dominance. Furthermore, increasing prevalence of chronic diseases such as arthritis, cancer, diabetes among others are anticipated to drive demand for oxaprozin in Asia Pacific region over the forecast period.
The European market was valued at USD X million in 2017 and is expected to grow at a CAGR of XX% from 2018 to 2030 owing high consumption of non-steroidal anti-inflammatory drugs (NSAIDs) including oxaprozin mainly due its low price compared with other NSAIDs available on prescription or over-the-counter (OTC).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. Oxaprozin Active Pharmaceutical Ingredients are used to treat a wide range of chronic diseases such as arthritis, pain, and inflammation. As a result, the demand for oxaprozin active pharmaceutical ingredients is expected to increase in the coming years.
- Growing awareness about health and wellness: There has been a growing awareness among people about the importance of leading a healthy lifestyle. This has led to an increase in the demand for preventive healthcare services and products such as oxaprozin active pharmaceutical ingredients.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxaprozin Active Pharmaceutical Ingredients Market Research Report
By Type
Purity (99%-99.5%), Purity (above 99.5%), Purity (below 99 %)
By Application
Reating Pain, Fever, Inflammation, Others
By Companies
Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Pfizer, Taj Pharmaceuticals Ltd, ScinoPharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Oxaprozin Active Pharmaceutical Ingredients Market Report Segments:
The global Oxaprozin Active Pharmaceutical Ingredients market is segmented on the basis of:
Types
Purity (99%-99.5%), Purity (above 99.5%), Purity (below 99 %)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Reating Pain, Fever, Inflammation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Granules India Limited
- Huagang Pharm
- Hebei Jiheng Pharmaceutical
- Zhejiang Kangle Pharmaceutical
- Pfizer
- Taj Pharmaceuticals Ltd
- ScinoPharm
Highlights of The Oxaprozin Active Pharmaceutical Ingredients Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity (99%-99.5%)
- Purity (above 99.5%)
- Purity (below 99 %)
- By Application:
- Reating Pain
- Fever
- Inflammation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxaprozin Active Pharmaceutical Ingredients Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxaprozin is an active pharmaceutical ingredient (API) that is used in the treatment of pain.
Some of the major players in the oxaprozin active pharmaceutical ingredients market are Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Pfizer, Taj Pharmaceuticals Ltd, ScinoPharm.
The oxaprozin active pharmaceutical ingredients market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oxaprozin Active Pharmaceutical Ingredients Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oxaprozin Active Pharmaceutical Ingredients Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oxaprozin Active Pharmaceutical Ingredients Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oxaprozin Active Pharmaceutical Ingredients Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oxaprozin Active Pharmaceutical Ingredients Market Size & Forecast, 2018-2028
4.5.1 Oxaprozin Active Pharmaceutical Ingredients Market Size and Y-o-Y Growth
4.5.2 Oxaprozin Active Pharmaceutical Ingredients Market Absolute $ Opportunity
Chapter 5 Global Oxaprozin Active Pharmaceutical Ingredients Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Type
5.2.1 Purity (99%-99.5%)
5.2.2 Purity (above 99.5%)
5.2.3 Purity (below 99 %)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oxaprozin Active Pharmaceutical Ingredients Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Applications
6.2.1 Reating Pain
6.2.2 Fever
6.2.3 Inflammation
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oxaprozin Active Pharmaceutical Ingredients Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oxaprozin Active Pharmaceutical Ingredients Analysis and Forecast
9.1 Introduction
9.2 North America Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Type
9.6.1 Purity (99%-99.5%)
9.6.2 Purity (above 99.5%)
9.6.3 Purity (below 99 %)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Applications
9.10.1 Reating Pain
9.10.2 Fever
9.10.3 Inflammation
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oxaprozin Active Pharmaceutical Ingredients Analysis and Forecast
10.1 Introduction
10.2 Europe Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Type
10.6.1 Purity (99%-99.5%)
10.6.2 Purity (above 99.5%)
10.6.3 Purity (below 99 %)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Applications
10.10.1 Reating Pain
10.10.2 Fever
10.10.3 Inflammation
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Type
11.6.1 Purity (99%-99.5%)
11.6.2 Purity (above 99.5%)
11.6.3 Purity (below 99 %)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Applications
11.10.1 Reating Pain
11.10.2 Fever
11.10.3 Inflammation
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oxaprozin Active Pharmaceutical Ingredients Analysis and Forecast
12.1 Introduction
12.2 Latin America Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Type
12.6.1 Purity (99%-99.5%)
12.6.2 Purity (above 99.5%)
12.6.3 Purity (below 99 %)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Applications
12.10.1 Reating Pain
12.10.2 Fever
12.10.3 Inflammation
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oxaprozin Active Pharmaceutical Ingredients Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Type
13.6.1 Purity (99%-99.5%)
13.6.2 Purity (above 99.5%)
13.6.3 Purity (below 99 %)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oxaprozin Active Pharmaceutical Ingredients Market Size Forecast by Applications
13.10.1 Reating Pain
13.10.2 Fever
13.10.3 Inflammation
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oxaprozin Active Pharmaceutical Ingredients Market: Competitive Dashboard
14.2 Global Oxaprozin Active Pharmaceutical Ingredients Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Granules India Limited
14.3.2 Huagang Pharm
14.3.3 Hebei Jiheng Pharmaceutical
14.3.4 Zhejiang Kangle Pharmaceutical
14.3.5 Pfizer
14.3.6 Taj Pharmaceuticals Ltd
14.3.7 ScinoPharm
